| Product Code: ETC088669 | Publication Date: Jun 2021 | Updated Date: Sep 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The radiopharmaceutical market in Vietnam is gaining prominence in the healthcare sector, driven by advancements in medical imaging and diagnostics. Radiopharmaceuticals play a crucial role in nuclear medicine, facilitating the diagnosis and treatment of various medical conditions. The market`s growth is supported by the increasing prevalence of chronic diseases and the expansion of healthcare infrastructure in Vietnam. Regulatory approvals and investments in research and development contribute to the diversification of radiopharmaceutical offerings in the country.
The Vietnam Radiopharmaceutical Market is driven by advancements in healthcare and the increasing need for diagnostic and therapeutic procedures. Radiopharmaceuticals play a vital role in nuclear medicine for diagnosing and treating various medical conditions, including cancer and cardiovascular diseases. With improvements in healthcare infrastructure and the rise in chronic illnesses, the market is expanding to meet these needs.
The Vietnam Radiopharmaceutical Market grapples with challenges related to regulatory approvals and safety standards. Radiopharmaceuticals are radioactive compounds used in medical imaging and therapy. Ensuring the safe handling, transportation, and disposal of these materials is of paramount importance. Regulatory compliance and strict safety standards must be adhered to, which can sometimes lead to delays in product approval and market entry. Moreover, the complexity of radiopharmaceutical production and the need for advanced infrastructure present logistical challenges for the market`s growth.
The Vietnam Radiopharmaceutical Market faced distinctive challenges and opportunities during the COVID-19 pandemic. Radiopharmaceuticals, essential in medical imaging and diagnostics, encountered disruptions in supply chains and healthcare services due to the focus on pandemic-related priorities. However, the market also witnessed increased demand for certain diagnostic procedures and therapeutic applications. The pandemic highlighted the importance of resilient healthcare infrastructure and the role of advanced medical technologies. As Vietnam`s healthcare system adapts to post-pandemic conditions, the Radiopharmaceutical Market is expected to recover, with ongoing advancements in medical imaging and diagnostics driving market growth.
In the Vietnam Radiopharmaceutical Market, leading players are at the forefront of advancing medical diagnostics and treatment. Companies such as MediScan Technologies, RadiaLife Sciences, and NucliaPharma contribute significantly to the market`s evolution. These key players specialize in the production and distribution of radiopharmaceuticals, playing a crucial role in enhancing healthcare outcomes. With a commitment to research and development, coupled with adherence to stringent quality standards, these players are instrumental in shaping the landscape of nuclear medicine in Vietnam.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Radiopharmaceutical Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Radiopharmaceutical Market - Industry Life Cycle |
3.4 Vietnam Radiopharmaceutical Market - Porter's Five Forces |
3.5 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Vietnam Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases leading to higher demand for diagnostic imaging procedures using radiopharmaceuticals |
4.2.2 Growing investments in healthcare infrastructure and facilities in Vietnam |
4.2.3 Rising awareness about the benefits of nuclear medicine and radiopharmaceuticals among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in the field of nuclear medicine and radiopharmaceuticals |
4.3.2 Stringent regulatory requirements and approval processes for radiopharmaceuticals in Vietnam |
4.3.3 Limited reimbursement options for radiopharmaceutical procedures in the healthcare system |
5 Vietnam Radiopharmaceutical Market Trends |
6 Vietnam Radiopharmaceutical Market, By Types |
6.1 Vietnam Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Types, 2021-2031F |
6.1.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.4 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.2 Vietnam Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.2.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2021-2031F |
6.3 Vietnam Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
6.4 Vietnam Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2021-2031F |
6.4.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2021-2031F |
6.5 Vietnam Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.5.4 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2021-2031F |
6.5.5 Vietnam Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2021-2031F |
6.5.6 Vietnam Radiopharmaceutical Market Revenues & Volume, By Others, 2021-2031F |
7 Vietnam Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Vietnam Radiopharmaceutical Market Export to Major Countries |
7.2 Vietnam Radiopharmaceutical Market Imports from Major Countries |
8 Vietnam Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of new nuclear medicine facilities or departments established in Vietnam |
8.2 Percentage increase in the adoption of advanced radiopharmaceutical imaging technologies |
8.3 Average waiting time for patients to undergo radiopharmaceutical procedures |
9 Vietnam Radiopharmaceutical Market - Opportunity Assessment |
9.1 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Vietnam Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Vietnam Radiopharmaceutical Market - Competitive Landscape |
10.1 Vietnam Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |